Yonjin Capital: Funding, Team & Investors | Startup Intros

Loading organizations...

Yonjin Capital: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Sep 8, 2025	Rapafusyn Pharmaceuticals	$44.0M Series A	—	Karen Liu, Jian Li, Haolin Sung, Wen Chen
Sep 1, 2024	CSA Medical	$53.0M Series D	TVM Capital, Yonjin Capital	Ascension Ventures, SV Health Investors
Aug 1, 2024	HistoSonics	$100.0M Series D	Chris Dimitropoulos	Johnson & Johnson Innovation, Sonder Capital, Amzak Health, HealthQuest Capital, Johnson & Johnson Innovation, Lumira Ventures, State of Wisconsin, State of Wisconsin Investment Board, Venture Investors
Dec 14, 2022	HistoSonics	$100.0M Debt / Other Equity	Johnson & Johnson Innovation	Lumira Ventures, Signature Bank, State of Wisconsin Investment Board, Venture Investors
Aug 24, 2022	Regenacy Pharmaceuticals	$9.3M Series B	Todd Kaloudis	3E Bioventures Capital
Aug 1, 2022	Bluejay Therapeutics	$41.0M Series B	Alon Lazarus In remembrance	Digitalis Ventures, RiverVest, InnoPinnacle Fund, Ting Jia (TJ), Nancy Hong, Bill Rutter
Dec 1, 2021	ITabMed	$20.0M Series A	Karen Liu, Wen Chen	Binhai Venture Capital
Mar 1, 2021	TechsoMed	$7.0M Series B	Axil Capital	4BIO Capital, Astellas Venture Management, Remiges Ventures, Cobro Ventures, Johnson & Johnson Innovation, Magna Capital Partners, NextLeap Ventures, Radianx Capital
Mar 1, 2021	OncoResponse	$41.0M Series C	Ted Koutouzis MD	125 Ventures, Canaan Partners, Commerce Ventures, GE Ventures, Thompson Hutton (Thompson Hutton), 3B Future Health Fund, ARCH Venture Partners, Bering Capital, Canaan Partners, Patrick Hojlo, CFA, Redmile Group, RiverVest Venture Partners, Daguan Wang
Sep 1, 2020	Libra Therapeutics	$29.0M Series A	Martin Heidecker, Henning Steinhagen, Saints Capital	AMR Action Fund, Mission BioCapital, Dolby Family Ventures, Sixty Degree Capital
Jun 30, 2020	Goldfinch Biopharma	$100.0M Series B	Joy Ghosh	Ally Bridge Group, BlackRock, Casdin Capital, Gilead Sciences, Irving Investors, Schroders Capital, Wellington Management
Jun 16, 2020	C4 Therapeutics, Inc.	$170.0M Debt / Series B	Todd Kaloudis, Adam Stone	3E Bioventures Capital, Adage Capital Management, Axil Capital, Bain Capital Life Sciences, Commodore Capital, HBM Healthcare Investments, Janus Henderson Investors, Lightchain Capital, Logos Capital, Mizuho Securities Principal Investment, Nextech, RA Capital Management, RTW Investments, Sphera Funds Management, T. Rowe Price Associates
Jun 8, 2020	HistoSonics	$40.0M Series C	Wen Chen	Johnson & Johnson Innovation, Lumira Ventures, State of Wisconsin Investment Board, Varian Medical Systems, Venture Investors
Mar 25, 2020	Regenacy Pharmaceuticals	$30.0M Series A	Marc Cohen	Frank Yan, Taya Ventures, Daguan Wang
Jan 1, 2019	Frequency Therapeutics	$42.0M Series B	Axil Capital	Joel Marcus, Marc Cohen, DF Investments, Emigrant Capital, Korea Investment Partners, Polaris Founders Capital, Daguan Wang